AARON THRIFT to Case-Control Studies
This is a "connection" page, showing publications AARON THRIFT has written about Case-Control Studies.
Connection Strength
1.406
-
Dietary Factors and Gastric Intestinal Metaplasia Risk Among US Veterans. Dig Dis Sci. 2021 05; 66(5):1600-1610.
Score: 0.093
-
Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans. Am J Gastroenterol. 2020 03; 115(3):381-387.
Score: 0.091
-
Editorial: less acid, less cancer? Is this the question? Authors' reply. Aliment Pharmacol Ther. 2018 10; 48(8):878-879.
Score: 0.082
-
Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic?Variants. Gastroenterology. 2018 04; 154(5):1273-1281.e3.
Score: 0.078
-
External Validation of the Michigan Barrett's Esophagus Prediction Tool. Clin Gastroenterol Hepatol. 2017 07; 15(7):1124-1126.
Score: 0.074
-
Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus. Am J Gastroenterol. 2016 11; 111(11):1528-1535.
Score: 0.071
-
Inverse Association Between Gluteofemoral Obesity and Risk of?Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol. 2016 10; 14(10):1412-1419.e3.
Score: 0.070
-
Premature Birth and Large for Gestational Age Are Associated with Risk of Barrett's Esophagus in Adults. Dig Dis Sci. 2016 Apr; 61(4):1139-47.
Score: 0.068
-
Mendelian randomization study of height and risk of colorectal cancer. Int J Epidemiol. 2015 Apr; 44(2):662-72.
Score: 0.065
-
Alcohol and the risk of Barrett's esophagus: a pooled analysis from the International BEACON Consortium. Am J Gastroenterol. 2014 Oct; 109(10):1586-94.
Score: 0.062
-
Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus. J Clin Gastroenterol. 2014 Mar; 48(3):218-23.
Score: 0.060
-
A multibiomarker risk score helps predict risk for Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Aug; 12(8):1267-71.
Score: 0.059
-
No significant effects of smoking or alcohol consumption on risk of Barrett's esophagus. Dig Dis Sci. 2014 Jan; 59(1):108-16.
Score: 0.058
-
Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol. 2013 Jun; 108(6):915-22.
Score: 0.056
-
A model to determine absolute risk for esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2013 Feb; 11(2):138-44.e2.
Score: 0.055
-
The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival. Int J Cancer. 2012 Sep 01; 131(5):E759-68.
Score: 0.052
-
Helicobacter pylori infection and the risks of Barrett's oesophagus: a population-based case-control study. Int J Cancer. 2012 May 15; 130(10):2407-16.
Score: 0.050
-
Lifetime alcohol consumption and risk of Barrett's Esophagus. Am J Gastroenterol. 2011 Jul; 106(7):1220-30.
Score: 0.049
-
A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization. Nat Commun. 2021 01 11; 12(1):246.
Score: 0.024
-
Sex Differences in the Risk of Barrett's Esophagus Associated With the Metabolic Effects of Obesity. J Clin Gastroenterol. 2020 10; 54(9):795-800.
Score: 0.024
-
Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology. 2020 12; 159(6):2065-2076.e1.
Score: 0.024
-
Risk Prediction Models for Barrett's Esophagus Discriminate Well and Are Generalizable in an External Validation Study. Dig Dis Sci. 2020 10; 65(10):2992-2999.
Score: 0.022
-
Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium. Cancer. 2019 12 01; 125(23):4210-4223.
Score: 0.022
-
Statin use and risk of liver cancer: Evidence from two population-based studies. Int J Cancer. 2020 03 01; 146(5):1250-1260.
Score: 0.022
-
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. Gastroenterology. 2018 12; 155(6):1828-1837.e2.
Score: 0.020
-
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. Br J Cancer. 2018 04; 118(8):1123-1129.
Score: 0.020
-
Factors That Contribute to Indeterminate Results From the?QuantiFERON-TB Gold In-Tube Test in Patients With?Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2018 10; 16(10):1616-1621.e1.
Score: 0.019
-
Symptoms of Obstructive Sleep Apnea, Gastroesophageal Reflux and the Risk of Barrett's Esophagus in a Population-Based Case-Control Study. PLoS One. 2015; 10(6):e0129836.
Score: 0.016